Search results
ImmuneCyte Life Sciences is a clinical-stage biopharmaceutical company focused on developing innovative cell and gene therapeutics for the treatment of cancer, vascular, orthopedic, and aging-related diseases. Use the CB Insights Platform to explore ImmuneCyte Life Sciences's full profile.
16 kwi 2020 · ImmuneCyte is a clinical stage cell therapy company focused on delivering critical impacts on cancer, vascular, orthopedic, and aging-related diseases.
Find company research, competitor information, contact details & financial data for ImmuneCyte Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.
ImmuneCyte is a multilingual, clinical-stage biopharmaceutical firm dedicated to the study and creation of alternative cell and gene medicines, such as CAR-NK, mononuclear, and T cells with chimeric antigen receptors, for the treatment of cancer, vascular, orthopaedic, and age-related illnesses.
13 kwi 2020 · Information on valuation, funding, acquisitions, investors, and executives for ImmuneCyte Life Sciences. Use the PitchBook Platform to explore the full profile.
ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including the fourth generation chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer and vascular diseases.
13 kwi 2020 · ImmuneCyte, which is a joint venture between ThermoGenesis Holdings Inc. and HealthBanks Biotech, acquired global intellectual property for four antibody drug candidates against SARS-CoV-2 — the virus that causes COVID-19 — and tools for screening and checking the efficacy of such antibodies.
